Inventor · disambiguated record
Janine Powers
Also filed as: POWERS JANINE
6 granted patents·7 pending applications·13 citations·filing 2010–2025
74Inventor score
Files withFIVE PRIME THERAPEUTICS INC7BRENNAN THOMAS2NURIX THERAPEUTICS INC2UCB BIOPHARMA SPRL1UCB Biopharma SRL1
Top patents by PatentIndex Score
13 records- 0186US8445445B2Method of promoting hair growth using FGFR4 extracellular domainsBRENNAN THOMAS·Filed 2010·Granted May 21, 2013·7 cites·22 claims
- 0281US8685931B2Hair growth methods using FGFR3 extracellular domainsBRENNAN THOMAS·Filed 2010·Granted Apr 1, 2014·6 cites·41 claims
- 0371US11975046B2Medical use of interferon-lambda for the treatment of fibrosisUCB Biopharma SRL·Filed 2023·Granted May 7, 2024·0 cites·10 claims
- 0469US2023052212A1Fgfr2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0565US2023192870A1Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pancreatic CancerFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0665US2025223367A1Fgfr2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0759US11421034B2Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancerFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Aug 23, 2022·0 cites·15 claims
- 0858US2024336595A1Bifunctional compounds for degrading btk with diminished imid activityNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0956US11447553B2FGFR2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Sep 20, 2022·0 cites·10 claims
- 1056US2023355599A1Biomarkers for cbl, and compositions and methods for their useNURIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1150US2014274898A1Hair growth methods using fgfr3 extracellular domainsFIVE PRIME THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1244US2019374610A1Medical use of interferon-lambda for the treatment of fibrosisUCB BIOPHARMA SPRL·Filed 2017·Application pending·0 cites
- 1343US10799559B2NOPE for treatment of pathological muscle loss and weaknessFIVE PRIME THERAPEUTICS INC·Filed 2017·Granted Oct 13, 2020·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Janine Powers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →